International Journal of Biomedicine. 2023;13(1):47-53.
Originally published March 3, 2023
Background: Some years ago, chronic diseases were considered to be a problem for the wealthy and elderly population. Today, chronic conditions affect the poor, young, and middle-aged people in high-income countries. The global prevalence of diabetes mellitus (DM) has been continuously growing for over half a century and has reached pandemic proportions. In the present study, we aimed to estimate the trends in prediabetes and DM prevalence and to determine related risk factors among Kosovo people from 2011 to 2019.
Methods and Results: A population-based survey was conducted among people aged 18-69 from April 2018 to June 2019 and those aged 15-64 using the WHO STEPs instrument. Detailed findings on the magnitude of DM and impaired fasting blood glucose (FBG) are presented in this paper.
Prevalence of prediabetes in 2011 at 15-64 years was 6.0% (95% CI, 4.6% - 7.9%), and in 2019 at 18-69 years was 6.1% (95% CI, 5.3% - 7.1%), not a significant difference (P>0.05). To avoid bias from different ages, we compared prevalence by age groups. Only in the age group of 35-44 we found a significant difference in the prevalence of prediabetes. In this age group, the prevalence of prediabetes was 2.4% (95% CI, 0.9%-6.1%) in 2011 and 2.7% (95%CI, 0.9%-6.1%) in 2019. In 2019, the prevalence of prediabetes was higher among males than in 2011, when females prevailed.
Prevalence of DM in 2011 at 15-64 years was 7.7% (95% CI, 6.0% - 9.7%), and in 2019 at 18 – 69 years was 7.9% (95% CI, 6.9% - 9.0%), not a significant difference (P>0.05). In the age groups of 45-54 and 55-64, we found a significant difference in the prevalence of DM by years. The prevalence of DM at 45-54 years was 13.5% (95% CI, 9.2% - 19.5%) in 2011 and 7.8% (95%CI, 6.0%-10.2%) in 2019 (P=0.032). The prevalence of DM at 55-54 years was 21.6% (95% CI, 15.8% - 28.9%) in 2011 and 13.2% (95%CI, 10.6%-16.3%) in 2019 (P=0.015). The prevalence of DM was higher among females in 2011 and 2019.
Conclusion: Results from 2 STEPS in Kosovo show that we have no significant increase in the prevalence of prediabetes and DM in total. At the same time, we found a significant decrease in DM in the age group 45-64.
- Heald AH, Stedman M, Davies M, Livingston M, Alshames R, Lunt M, Rayman G, Gadsby R. Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data. Cardiovasc Endocrinol Metab. 2020 Jun 2;9(4):183-185. doi: 10.1097/XCE.0000000000000210.
- International Diabetes Federation (IDF). IDF Diabetes Atlas 2021. International Diabetes Federation; 2021. Available from: https://diabetesatlas.org/atlas/tenth-edition/
- WHO. World health statistics 2021: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2021.
- Fottrell E, Ahmed N, Shaha SK, Jennings H, Kuddus A, Morrison J, Akter K, Nahar B, Nahar T, Haghparast-Bidgoli H, Khan AKA, Costello A, Azad K. Distribution of diabetes, hypertension and non-communicable disease risk factors among adults in rural Bangladesh: a cross-sectional survey. BMJ Glob Health. 2018 Nov 12;3(6):e000787. doi: 10.1136/bmjgh-2018-000787.
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016 Apr 9;387(10027):1513-1530. doi: 10.1016/S0140-6736(16)00618-8. Epub 2016 Apr 6. Erratum in: Lancet. 2017 Feb 4;389(10068):e2.
- United Nations. Resolution adopted by the General Assembly on 20 December 2006. 61/225. World Diabetes Day; 2006. Available from: https://www.wddj.jp/pdf/UN_Resolution.pdf
- National Institute of Public Health of Kosovo. Department of Health Statistics. Health statistics report. Report of survey on risk factors for chronic disease. Pristina. 2011-2021.
- Statistical Office of Kosovo. Causes of death in Kosovo 2018 and 2019. Pristina, December 2020.
- World Health Organization. STEPwise approach to NCD risk factor surveillance (STEPS). (Last accessed 06.01.2022). Available from: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-...
- Gashi S. Prevalence of chronic diseases risk factors and specific health determinants in a transitional country- The case of Kosovo. School of Medicine, University of Zagreb. Dissertation, Zagreb 2018.
- WHO STEPs surveillance manual: the WHO STEPwise approach to chronic disease risk factor surveillance. Geneva: World Health Organization. Available from: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps/manuals
- Epi Info [download and information page]. Atlanta (GA): Centers for Disease Control and Prevention (Available from: https://www.cdc.gov/epiinfo/index.html).
- World Health Organization. Tackling NCDs:'best buys' and other recommended interventions for the prevention and control of noncommunicable diseases. World Health Organization; 2017.
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843.
- Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes Mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology. 2021 Apr 16;2(2):36-50.
- Centers for Disease Control and Prevention. National Diabetes Statistics Report website. Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html
- Institute for Public Health of the Republic N. Macedonia, Center for statistical processing health data, publication and education, Skopje 2019-2020.
- Institute of Public Health, National Report on Non-Communicable Diseases, Mortality, Injury and Risk Factors. Tirana 2019.
- World Health Organization. WHO global health estimates: 2000-2019. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
- Tirimacco R, Tideman PA, Dunbar J, Simpson PA, Philpot B, Laatikainen T, Janus E. Should capillary blood glucose measurements be used in population surveys? International Journal of Diabetes Mellitus. 2010 Apr 1;2(1):24-7.
- Carstensen B, Lindström J, Sundvall J, Borch-Johnsen K, Tuomilehto J; DPS Study Group. Measurement of blood glucose: comparison between different types of specimens. Ann Clin Biochem. 2008 Mar;45(Pt 2):140-8. doi: 10.1258/acb.2007.006212.
Received January 13, 2023.
Accepted February 15, 2023.
©2023 International Medical Research and Development Corporation.